Volume 28, Issue 1 (Spring 2022)                   IJPCP 2022, 28(1): 138-143 | Back to browse issues page


XML Persian Abstract Print


1- Department of Psychiatry, Faculty of Medicine, Research Center of Addiction and Risky Behavior, Iran University of Medical Sciences, Tehran, Iran.
2- Department of Psychiatry, Iran University of Medical Sciences, Tehran, Iran.
3- Department of Psychiatry, Faculty of Medicine, Research Center of Addiction and Risky Behavior, Iran University of Medical Sciences, Tehran, Iran. , m.faramarzi89@yahoo.com
Abstract:   (9232 Views)
Synthetic cannabinoids (SC) are a heterogeneous group of substances with a high affinity for cannabinoid receptors. Unlike Δ9-tetrahydrocannabinol (THC), synthetic cannabinoids are incredibly potent, highly productive, have more affinity for the cannabinoid receptor type 1 (CB1), and cannabinoid receptor type 2 (CB2), and are designed to accelerate the effects of tetrahydrocannabinol. Also, there is experimental evidence that SCs act on non-cannabinoid receptors, such as the 5-HT2B receptor or dopaminergic receptors.
Full-Text [PDF 1020 kb]   (1798 Downloads) |   |   Full-Text (HTML)  (1969 Views)  
Type of Study: Letter to the editor | Subject: Psychiatry and Psychology
Received: 2021/08/9 | Accepted: 2021/11/29 | Published: 2022/04/20

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.